|
|
Media Contact:
Devendra Mishra
Executive Director
Phone: 818-224-1552
|
|
“COMMERCIALIZATION OF CELL & GENE THERAPY: ADVANCING TECHNOLOGY AND INNOVATION” |
|
A Virtual Mini-Conference:
CELL & GENE THERAPY TRANSFORM OF BIOTECH
|
|
BSMA, the premiere global alliance of supply chain management professionals in Life Sciences, is bringing together the stakeholders of the embryonic Cell and Gene Therapy to confront its formidable challenge of commercialization.
The innovative therapy of Cell and Gene Therapy has imposed Draconian demands on the supply chain in terms of production batch of one, sixteen-day vein to vein lead time, cryogenic preservation and cold-chain logistics, chain of custody, real-time patient care, and prohibitive cost of treatment. Executives of CGT companies and service providers will address the “Issues and Answers” of raw material supply, supplier QA, apheresis, scale out of clinical and manufacturing operations, distribution and logistics, information systems, governmental compliance and efficacy of treatment.
|
|
DATE: August 5, 2021
TIME: 9:00 AM – 1:00 PM
|
|
PRELIMINARY EVENT PROGRAM |
|
"Welcome To the Revolution in Healthcare"
Devendra Mishra, Executive Director, BSMA
Arun Sivanandam, Chief Science & Innovation Officer, BSMA
|
|
KEYNOTE: “The Unique Technology Platform: Destroyer of Cancerous Tumors”
Timothy Moore, President, PACT Pharma
|
|
PANEL: “Overcoming the Challenges of Cell and Gene Therapy: The Lifeline of the Healthcare Revolution”
Aileen Baquiran, Vice President, Supply Chain, Orchard Therapeutics
Chris Bogart, Vice President, Supply Chain, Bayer
Matt Yedwabnick, VP, Global Supply Chain, Atara Biotherapeutics
Kevin Cast, Partner, Archbow Consulting
Moderator: Devendra Mishra, Executive Director, BSMA
|
|
PANEL: “Harmonizing Best Supply Chain Practices for Apheresis”
Dawn Henke, Senior Technical Program Manager, Standards Coordinating Body
Olive Sturtevant, Sr. Administrative Director, Connell & O’Reilly Families, Cell Manipulation Core Facility, Dana-Farber Cancer Institute
Gary Hutchinson, President, Modality Solutions
Gregg Bodnar, Senior Client Engagement Manager, Be The Match BioTherapies
Devendra Mishra, Executive Director, BSMA
Moderator: Peter Holman, Global Apheresis Integration Lead and Head of Apheresis Operations, Novartis
|
|
“Navigating the Process Development Challenges of Cell & Gene Therapy”
SPEAKER: Kenny Choi, Senior Director. Process Sciences and Engineering, Instil Bio
|
|
“How to Industrialize Strategic Sourcing of Raw Materials and Supplies?”
David Karakas, Director, Procurement & Sourcing, Bluebird Bio
|
|
"Scale Up of CGT Manufacturing"
SPEAKER: TBA
|
|
"System Solutions for A Digital Supply Chain of CGT"
SPEAKER: TBA
|
|
“Labeling, Packaging & Logistics – The Achilles Heel of the CGT Delivery”
SPEAKER: Mathew Letow, Senior Director, Business Development, AmerisourceBergen (ICS)
|
|
Wrap Up: "Where do we go from here?"
Devendra Mishra, Executive Director, BSMA
|
|
Presenting: The Speakers and Panelists |
|
BSMA - Driving Innovation in the Life Sciences Supply Chain
Since its inception in 2007, BSMA is a global organization that fosters Innovation and Adoption of disruptive technologies within the end-to-end supply chain of the Life Sciences industry. With offices in California (USA), Brussels (Belgium) and Mumbai (India), BSMA promotes collaboration and networking between professionals of the biotech, pharmaceutical, academic and medical diagnostics enterprises. The Alliance partners with industry, academia, foundations, suppliers, technology enablers, research institutions, trade organizations and the government to improve productivity, quality, product and service integrity, risk mitigation, managerial talent development and patient care globally. It is also the home of start-up companies engaged in business development and scale up.
|
|
|
|
|
|
|
